Federated Hermes
BPMC

Federated Hermes’s Blueprint Medicines BPMC Stock Holding History

Federated Hermes’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-156,284
Closed -$13.6M – 2070
2024
Q4 		$13.6M Buy
156,284
+2,983
+2% +$273K 0.03% 490
2024
Q3 		$14.2M Buy
153,301
+90,947
+146% +$9.03M 0.03% 497
2024
Q2 		$6.72M Buy
62,354
+13,579
+28% +$1.36M 0.02% 639
2024
Q1 		$4.63M Buy
48,775
+24,732
+103% +$2.12M 0.01% 745
2023
Q4 		$2.22M Buy
+24,043
New +$1.56M 0.01% 922
2022
Q1 		– Sell
-388
Closed -$42K – 2199
2021
Q4 		$42K Sell
388
-26
-6% -$2.72K ﹤0.01% 1810
2021
Q3 		$43K Sell
414
-43,843
-99% -$4.08M ﹤0.01% 1875
2021
Q2 		$3.89M Sell
44,257
-30,950
-41% -$2.84M 0.01% 899
2021
Q1 		$7.31M Sell
75,207
-41,267
-35% -$4.12M 0.01% 751
2020
Q4 		$13.1M Buy
116,474
+107,534
+1,203% +$11.3M 0.03% 571
2020
Q3 		$829K Buy
+8,940
New +$688K ﹤0.01% 1316
2019
Q4 		– Sell
-6
Closed -$1K – 2214
2019
Q3 		$1K Sell
6
-142,748
-100% -$12.3M ﹤0.01% 2079
2019
Q2 		$13.5M Buy
+142,754
New +$11.8M 0.03% 477
2018
Q2 		– Sell
-74,933
Closed -$6.87M – 2201
2018
Q1 		$6.87M Buy
+74,933
New +$6.46M 0.02% 532
2017
Q3 		– Sell
-32,487
Closed -$1.65M – 2143
2017
Q2 		$1.65M Buy
32,487
+8,607
+36% +$365K ﹤0.01% 1014
2017
Q1 		$955K Hold
23,880
– – ﹤0.01% 1185
2016
Q4 		$670K Buy
23,880
+4,618
+24% +$139K ﹤0.01% 1240
2016
Q3 		$572K Buy
+19,262
New +$478K ﹤0.01% 1247

Other funds holding BPMC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Federated Hermes's BPMC Position: Q1 2025 in Review

Federated Hermes sold out of Blueprint Medicines (BPMC) in Q1 2025, closing a stake of 156,284 shares — an estimated $13.6M sold.

Federated Hermes first reported a position in BPMC in Q3 2016 and held it in 18 quarters. The position peaked at $14.2M in Q3 2024. 352 funds tracked by Wall St. Rank hold BPMC as of Q1 2025.

  • Federated Hermes reported no remaining Blueprint Medicines position as of Q1 2025 after selling out during the quarter.
  • Federated Hermes sold 156,284 Blueprint Medicines shares in Q1 2025, an estimated $13.6M.
  • Federated Hermes first reported a position in Blueprint Medicines in Q3 2016 and held it in 18 quarters.
  • Federated Hermes's Blueprint Medicines position peaked at $14.2M in Q3 2024.
  • 352 funds tracked by Wall St. Rank held Blueprint Medicines as of Q1 2025.

Based on Federated Hermes's 13F filing for Q1 2025, filed 8 May 2025.